$200 Million+ Long-Term Manufacturing Agreement with Global Pharmaceutical Company
Led the renegotiation and restructuring of a long-term manufacturing agreement with a global pharmaceutical company, a complex arrangement spanning more than 10 years and valued in excess of $200 million. Each party to the agreement had global revenues in excess of $25 billion.
